Corrigendum to: Nanocochleates in Clinical Trials: A Review of Current Status, Challenges, and Future Directions.

IF 2.3 4区医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

Current drug metabolism Pub Date : 2026-01-01 DOI:10.2174/1389200227999260101093423

Alka Singh, Sushma Verma

引用次数: 0

Abstract

In the article titled "Nanocochleates in Clinical Trials: A Review of Current Status, Challenges, and Future Directions", published in Current Drug Metabolism, 2025, 26(6), 390-401 [1], the in-text citation of references [100, 101] was inadvertently included in Table 2 of the original version of the manuscript. The original article can be found online at: https://www.eurekaselect.com/article/150830.

查看原文本刊更多论文

临床试验中的纳米酸盐：现状、挑战和未来方向的回顾。

在发表于《Current Drug Metabolism》，2025,26(6)，390-401 b[1]的题为“Nanocochleates In Clinical Trials: A Review of Current Status, Challenges, and Future Directions”的文章中，参考文献[100,101]的文本引文被无意中包含在原稿的表2中。原文可在https://www.eurekaselect.com/article/150830网站上找到。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current drug metabolism 医学-生化与分子生物学

CiteScore

4.30

自引率

4.30%

发文量

审稿时长

4-8 weeks

期刊介绍： Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism. More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.